By Mill Chart
Last update: Sep 28, 2022
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Ticker | Change | Comment |
---|---|---|
PRTA | 59.39% | PROTHENA CORP PLC's (NASDAQ:PRTA) shares rose 59.39% to $49.3. In the last 6 months the share price dropped with 20.81%. |
BIIB | 53.95% | BIOGEN INC's (NASDAQ:BIIB) stock price is advancing with 53.95% to a price of $304.5. The stock is trading 30.34% lower than a year ago. |
LGVN | 27.79% | LONGEVERON INC's (NASDAQ:LGVN) shares rose 27.79% to $5.15. In the last month the stock lost 24.11%. |
BNTC | 18.92% | BENITEC BIOPHARMA INC's (NASDAQ:BNTC) shares rose 18.92% to $0.38 during Wednesday's pre-market session. In the last month the stock lost 55.44%. |
NNOX | 16.42% | NANO-X IMAGING LTD's (NASDAQ:NNOX) shares rose 16.42% to $11.84. The stock is trading 23.36% lower than a month ago. |
EFOI | 15.05% | ENERGY FOCUS INC (NASDAQ:EFOI) rose 15.05% to $0.61 during Wednesday's pre-market session. The stock is trading 29.77% lower than a month ago. |
BIVI | 14.4% | BIOVIE INC's (NASDAQ:BIVI) shares rose 14.4% to $2.7 during Wednesday's pre-market session. In the last month the stock lost 26.48%. |
TENX | 14.34% | TENAX THERAPEUTICS INC (NASDAQ:TENX) rose 14.34% to $0.19 during Wednesday's pre-market session. The stock is trading 32.08% lower than a month ago. |
IGC | 14.0% | INDIA GLOBALIZATION CAPITAL's (NYSEARCA:IGC) shares rose 14.0% to $0.48. In the last month the share price dropped with 23.84%. |
ELYS | 13.94% | ELYS GAME TECHNOLOGY CORP's (NASDAQ:ELYS) shares rose 13.94% to $0.53 during Wednesday's pre-market session. In the last 3 months the stock lost 30.16%. |
For the full premarket gainers list go to our premarket gainers screener.
Ticker | Change | Comment |
---|---|---|
MNMD | -38.07% | MIND MEDICINE MINDMED INC's (NASDAQ:MNMD) shares fell 38.07% to $3.79 during Wednesday's pre-market session. In the last month the share price dropped with 49.04%. |
PHAS | -36.84% | PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) shares fell 36.84% to $0.48 during Wednesday's pre-market session. In the last month the stock lost 32.74%. |
IBIO | -33.58% | IBIO INC's (NYSEARCA:IBIO) shares fell 33.58% to $0.21 during Wednesday's pre-market session. In the last 3 months the share price increased with 21.54%. |
LTRYW | -28.79% | LOTTERY.COM -CW21's (NASDAQ:LTRYW) stock price is declining with 28.79% to a price of $0.01. In the last month the share price dropped with 37.93%. |
NA | -27.67% | NANO LABS LTD-ADR's (NASDAQ:NA) shares fell 27.67% to $2.3. NASDAQ:NA already had a hard day yesterday: closing -15.83% lower during the regular session. Yesterday the company had a press release: Nano Labs Ltd Announces Pricing of Public Offering of American Depositary Shares. |
ATXI | -18.18% | AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares fell 18.18% to $5.94 during Wednesday's pre-market session. After yesterdays gain of 106.0%, it goes down with 18.18% in today's pre-market session. |
GMDA | -17.86% | GAMIDA CELL LTD's (NASDAQ:GMDA) shares fell 17.86% to $1.61 during Wednesday's pre-market session. A press release (Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing) was released yesterday. |
PBTS | -11.5% | POWERBRIDGE TECHNOLOGIES CO's (NASDAQ:PBTS) shares fell 11.5% to $0.53. After running up 19.31% in yesterday's session, NASDAQ:PBTS is pulling back pre-market. |
CGNT | -11.36% | COGNYTE SOFTWARE LTD's (NASDAQ:CGNT) stock price is declining with 11.36% to a price of $3.9. The company's earnings where released Yesterday. Earlier today the company had a press release: Cognyte Announces Second Quarter Results. |
FHS | -10.96% | FIRST HIGH-SCHOOL EDUCAT-ADR's (NYSE:FHS) shares fell 10.96% to $0.65. In the last 6 months the stock lost 51.97%. |
For the full premarket loser list go to our premarket losers screener.
BENITEC BIOPHARMA INC
NASDAQ:BNTC (4/17/2024, 7:00:01 PM)
Premarket: 5.78 +0.98 (+20.42%)4.8
+0.02 (+0.42%)
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients...
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...
Learn about the prospectus filed by Benitec Biopharma for the offer and sale of mixed securities, up to $125,000,000.
-First Subject Dosed with BB-301 in Phase 1b/2a Clinical Treatment Study (NCT06185673) in November 2023- -Data Safety Monitoring Board Review for First...
HAYWARD, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene...
Benitec Biopharma, a genetic medicines company, releases updates on OPMD program and other corporate and financial updates....
Received FDA Clearance of the Investigational New Drug (IND) application for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)-Related...
HAYWARD, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...
Benitec Biopharma (BNTC) priced its underwritten public offering of ~15.54M shares and warrants to purchase up to ~15.54M shares.The offering is expected to close on August...
HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...
A renewed fight against COVID-19 might be coming.